Skip to main

Top Losers

Last updated Jan 10, 2026 at 11:55 PM

Discover today’s top-losing stocks with real-time data to help investors and traders stay informed on the latest market shifts. This data includes the 50 US-listed stocks with the steepest losses, with key financial metrics like daily change, market cap, trading volume, and daily highs and lows.

Invest in stocks and more on Public

Public is an all-in-one investing platform where you can build a multi-asset portfolio that includes everything from stocks and options to bonds, crypto, and a High-Yield Cash Account.

Sign up now
NamePriceChangeMarket CapVolumeAnalyst RatingHigh TodayLow Today
BBNX
Beta Bionics Inc
$20.14-37.04%886.66M8.3M$23.92$20.02
Trade
AQST
Aquestive Therapeutics Inc
$3.91-37.04%477.04M43.71M$4.15$3.59
STSS
Sharps Technology Inc
$1.89-27.03%75.1M5.7M$2.04$1.65
ATRA
Atara Biotherapeutics
$13.67-21.62%98.57M852.26K$17.98$13.08
PRQR
ProQR Therapeutics
$1.77-15.71%186.23M1.32M$2.12$1.74
ESLA
Estrella Immunopharma Inc
$1.20-15.49%50.45M184.69K$1.51$1.07
VTVT
vTv Therapeutics
$35.58-13.36%161.7M30.23K$41.44$33.69
ALGS
Aligos Therapeutics
$9-12.88%55.39M88.91K$10.45$9
FBYD
Falcon's Beyond Global Inc
$11.37-11.93%550.43M200.91K$12.95$10.67
FLYX
flyExclusive Inc
$6.39-11.62%132.65M9.91M$6.99$5.83
CDLX
Cardlytics
$1.35-11.18%72.98M1.31M$1.56$1.33
AXTI
AXT
$22.99-10.99%1.28B18.18M$26.30$21.43
ARMP
Armata Pharmaceuticals Inc
$7.05-10.65%256.67M58.49K$7.91$6.88
NUKK
Nukkleus Inc
$3.81-10.47%63.34M2.05M$4.23$3.80
SLS
SELLAS Life Sciences Group
$3.46-10.36%549.83M17.57M$3.65$3.23
GBX
Greenbrier Companies
$47.86-10.27%1.49B1.69M$52.95$47.18
PCRX
Pacira Pharmaceuticals
$23.53-9.57%1.02B2.45M$24.91$22.52
DWTX
Dogwood Therapeutics, Inc.
$2.85-9.52%84.73M140.74K$3.23$2.70
URGN
UroGen Pharma
$21.25-9.46%1.1B852.07K$24.10$21.18
ACRV
Acrivon Therapeutics Inc
$1.75-9.33%55.23M4.67M$2.02$1.75
DDD
3D Systems
$2.33-8.98%299.96M13.71M$2.72$2.21
TLYS
Tilly's
$1.66-8.79%55.47M126.35K$1.84$1.66
HROW
Harrow Health Inc
$46.78-8.35%1.74B842.59K$51.07$46.54
KMTS
Kestra Medical Technologies Inc
$24.43-8.33%1.43B283.63K$27.55$24.03
CBUS
Cibus Inc
$1.88-8.29%99.1M398.32K$2.10$1.86
EP
Empire Petroleum Corp
$2.90-8.23%101.09M52.13K$3.13$2.82
RIGL
Rigel Pharmaceuticals
$40.84-8.22%741.3M694.35K$45.25$40.75
OSS
One Stop Systems
$8.07-8.19%197.85M3.46M$9.00$7.95
ENTX
Entera Bio Ltd
$1.60-8.05%73.38M258.09K$1.78$1.60
ODD
Oddity Tech Ltd
$35.42-8.02%1.98B1.82M$38.97$35.32
BTM
Bitcoin Depot Inc
$1.31-7.75%95.91M861.52K$1.44$1.31
RXST
RxSight
$8.84-7.63%363.48M3.44M$9.63$8.64
ASPS
Altisource
$6.54-7.63%71.9M33.18K$7.08$6.49
MDGL
Madrigal Pharmaceuticals
$514.06-7.58%11.68B703.26K$555.10$511.03
LVRO
Lavoro Ltd
$1.12-7.44%128.35M243.09K$1.24$1.02
MMSI
Merit Medical Systems
$86.38-7.30%5.13B1.61M$93.41$84.75
PRE
Prenetics Global Ltd
$15.53-7.28%219.07M271.54K$16.96$15.29
ADAG
Adagene
$1.53-7.27%72.12M61.02K$1.75$1.50
CTEV
Claritev Corp
$28.94-7.27%478.26M212.41K$30.90$28.34
NAUT
Nautilus Biotechnology
$2.06-7.21%260.19M348.67K$2.24$2.02
MRUS
Merus
$90-7.14%6.83B2.73M$96.86$87.14
OMER
Omeros
$12.49-7.14%885.55M4.59M$14.25$12.45
MIST
Milestone Pharmaceuticals Inc
$2.04-6.85%173.75M6.37M$2.19$1.98
CAPR
Capricor Therapeutics
$23.84-6.69%1.3B2.61M$26.20$23.15
WVE
Wave Life Sciences
$13.84-6.68%2.72B3.75M$15.08$13.76
BIOX
Bioceres Crop Solutions Corp
$1.26-6.67%79.67M648.4K$1.38$1.25
TGTX
TG Therapeutics
$28.47-6.66%4.85B3.26M$30.90$28.21
COLL
Collegium Pharmaceutical
$45.54-6.64%1.44B675.07K$49.04$45.01
WDFC
WD-40
$190-6.63%2.76B839.43K$196.44$175.38
NSPR
InspireMD
$1.72-6.52%72.88M47.74K$1.83$1.69

*Analyst Ratings available to Premium Members only.

Market data by Xignite. In order to offer the best user experience, certain criteria were applied - Stocks with a market capitalization of less than 50 million, All OTC (over-the-counter) stocks, penny stocks (trading below $1 value), as well as stocks with an average daily volume of less than 10,000 over the past three months or less than 100,000 intraday volume were excluded from the dataset.

Please note that while we strive to provide accurate and up-to-date information, stock prices and other data may fluctuate and should be verified independently. We encourage users to conduct thorough research before making any investment decisions based on the information provided.